These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3522061)

  • 21. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
    Brandão AP; Oigman W; Albanesi Filho FM
    Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
    [No Abstract]   [Full Text] [Related]  

  • 22. [Captopril in the therapy of resistant hypertension. A multicenter study].
    Mion Júnior D; Silva HB; Marcondes M
    Arq Bras Cardiol; 1983 May; 40(5):363-7. PubMed ID: 6360101
    [No Abstract]   [Full Text] [Related]  

  • 23. Advantages and benefits of once-daily nadolol treatment in hypertension.
    González D
    J Int Med Res; 1982; 10(5):351-6. PubMed ID: 6754507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Crystepin T (Trimecryton). Multi-center evaluation of a anti-hypertensive agent containing a beta blocker].
    Mayer O; Cepelák V; Cícha Z; Kokaisl V; Mádle A; Mazanec J; Moses K; Vácha J
    Cas Lek Cesk; 1983 Jul; 122(29):906-12. PubMed ID: 6137281
    [No Abstract]   [Full Text] [Related]  

  • 25. [Captopril in the treatment of arterial hypertension in the elderly patient].
    Vitale P; Agretto A; De Stefano R; Manzo M; Villani C; Russo G
    Clin Ter; 1986 May; 117(3):213-7. PubMed ID: 3524973
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of oxodoline in patients with arterial hypertension].
    Mikunis RI; Serkova VK; Kaminskaia NA
    Klin Med (Mosk); 1988 Jan; 66(1):55-7. PubMed ID: 3283440
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in the medical management of renovascular hypertension.
    Vidt DG
    Urol Clin North Am; 1984 Aug; 11(3):417-24. PubMed ID: 6087531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative effects of captopril and chlorthalidone on glucose tolerance and insulin levels essential hypertensives].
    Zanella MT; Baptista M; Costa CH; Kohlmann NE; Kohlmann Júnior O; Ribeiro AB
    Arq Bras Cardiol; 1996 Jul; 67(1):47-52. PubMed ID: 9035467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
    Fogari R; Zoppi A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How effective is doxazosin compared with chlorthalidone in the treatment of hypertension?
    Koval PG; McDiarmid T
    J Fam Pract; 2000 Jul; 49(7):597-8. PubMed ID: 10923564
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term efficacy of captopril in the treatment of moderate/intensive arterial hypertension resistant to 3 antihypertensive drugs].
    Oliván J; Miranda MJ; Chozas J; Gras BX; Garrido M
    Med Clin (Barc); 1985 Nov; 85(14):571-4. PubMed ID: 3908849
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ambulatory treatment of hypertension with the beta-blockader corgard (nadolol)].
    Charyev KhE; Erina EV; Iurenev AP; Lediasheva GA
    Ter Arkh; 1984; 56(11):43-6. PubMed ID: 6523386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
    Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
    Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-therapeutic evaluation of the hypertensive patient by the isometric exertion test].
    Maiorano G; Contursi V; Petrelli G; Loiacono N; Bovenzi F; Ricapito M
    Minerva Cardioangiol; 1986 Mar; 34(3):107-17. PubMed ID: 3714062
    [No Abstract]   [Full Text] [Related]  

  • 36. Once-a-day therapy in patients with moderate-to-severe hypertension.
    McChesney JA
    J Natl Med Assoc; 1984 Jul; 76 Suppl(Suppl):47-53. PubMed ID: 6471122
    [No Abstract]   [Full Text] [Related]  

  • 37. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
    Carpentiere G; Marino S; Castello F
    Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of crystepin and obsidan in patients with hypertension].
    Leviashvili BI
    Vrach Delo; 1986 Mar; (3):22-4. PubMed ID: 2872750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.